| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0092 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |